Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1994-09-14
1997-04-22
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424489, 424463, 424486, 424482, A61K 916, A61K 950
Patent
active
056227213
ABSTRACT:
The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical composition which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms prohibit the exposure of the risedronate active ingredient to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach and thereby protects said tissues from erosion, ulceration or other like irritation. Accordingly, the said dosage forms effect the delivery to the lower gastrointestinal tract of said human or other mammal of a safe and effective amount of the risedronate active ingredient, and substantially alleviate the esophagitis or esophageal irritation which occasionally accompanies the oral administration of risedronate active ingredients.
REFERENCES:
patent: 4716041 (1987-12-01), Kjornaes
patent: 4786505 (1988-11-01), Lovgren
patent: 5096717 (1992-03-01), Wirth et al.
patent: 5431920 (1995-07-01), Bechard et al.
Axelrod Douglas W.
Dansereau Richard J.
Mosher Russell Y.
Sietsema William K.
Benston, Jr. William E.
Clark K. F.
McMahon M. P.
Page Thurman K.
Rasser J. C.
LandOfFree
Dosage forms of risedronate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage forms of risedronate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms of risedronate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339963